The melanin-producing Muse cells were produced from autologous iPS cells by a technology developed in Tohoku University’s Clio Co. under a NEDO contract and transferred to DS Pharma Biomedical Co. for commercial exploitation, mainly as a cosmetic test model. Future applications may also be for malignant tumors of the skin.

NEDO news release, Dec. 11., 2014